AstraZeneca today announced that it has entered into a five-year research collaboration with the Harvard Stem Cell Institute to adapt a technique that creates human beta cells from stem cells for use in screens of AstraZeneca’s compound library in the search for new treatments for diabetes.
from The Medical News http://ift.tt/1BrAaVS
from The Medical News http://ift.tt/1BrAaVS
No comments:
Post a Comment